Bellevue Group Ag Generation Bio Co. Transaction History
Bellevue Group Ag
- $5.98 Billion
- Q2 2024
A detailed history of Bellevue Group Ag transactions in Generation Bio Co. stock. As of the latest transaction made, Bellevue Group Ag holds 3,918,856 shares of GBIO stock, worth $9.37 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,918,856
Previous 3,861,575
1.48%
Holding current value
$9.37 Million
Previous $15.7 Million
29.68%
% of portfolio
0.18%
Previous 0.25%
Shares
13 transactions
Others Institutions Holding GBIO
# of Institutions
82Shares Held
50MCall Options Held
100Put Options Held
200-
Price T Rowe Associates Inc Baltimore, MD9.51MShares$22.7 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$19.8 Million3.11% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$7.87 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$7.13 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N42.83MShares$6.77 Million0.51% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $141M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...